CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

3-line summary

• CD&R and McKesson agreed to acquire at-home infusion therapy provider Option Care Health for $5.8 billion, according to a WSJ report.
• Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%.

This summary is our own processing of the source article; see the source link below for full context.